Expansion of human CMV-specific cytotoxic T lymphocytes to a clinical scale: a simple culture system using tetrameric HLA–peptide complexes

References

• Boeckh M, Gooley TA, Myerson D et al. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Blood 1996;88:4063–71.
   PubMed Web of Science ®Google Scholar
• Knox KK, Drobyski WR, Carrigan DR. Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient Lancet 1991;337:1292–3.
   Google Scholar
• Li CR, Greenberg PD, Gilbert MJ et al. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 1994;83:1971–9.
   PubMed Web of Science ®Google Scholar
• Quinnan GVJr, Kirmani N, Rook AH etal. Cytotoxic T cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med 1982;307:7–13.
   Google Scholar
• Reusser P, Riddell SR, MeyersJD etal. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 1991;78: 1373–80.
   Google Scholar
• Papadopoulos EB, Ladanyi M, Emanuel D et al. Infusions of donor leukocytes to treat Epstein—Barr virus-associated lym- phoproliferative disorders after allogeneic bone marrow trans-plantation. NEngl J Med 1994;330:1185–91.
   PubMed Web of Science ®Google Scholar
• Rooney CM, Smith CA, Ng CY etal. Infusion of cytotoxic T cells for the prevention and treatment of Epstein—Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 1998;92:1549–55.
   Google Scholar
• Riddell SR, Watanabe KS, Goodrich JM et al. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992;257:238–41.
   PubMed Web of Science ®Google Scholar
• Peggs K, Verfuerth S, Mackinnon S. Induction of cytomegalo-virus (CMV)-specific T-cell responses using dendritic cells pulsed with CMV antigen: a novel culture system free of live CMV virions. Blood 2001;97:994–1000.
   Google Scholar
• Szmania S, Galloway A, Bruorton M et al. Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers. Blood 2001;98:505–12.
   PubMed Web of Science ®Google Scholar
• Kleihauer A, Grigoleit U, Hebart H etal. Ex vivo generation of human cytomegalovirus-specific cytotoxic T cells by peptide-pulsed dendritic cells. Br J Haematol 2001113:231–9.
   Google Scholar
• Vannucchi AM, Glinz S, Bosi A etal. Selective ex vivo expansion of cytomegalovirus-specific CD4 and CD8T lymphocytesusing dendritic cells pulsed with a human leucocyte antigen A0201-restricted peptide. Br J Haematol 2001;113:479–82.
   Google Scholar
• Schmidt GM, Horak DA, Niland JC et al. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group. N Engl J Med 1991;324:1005–11.
   PubMed Web of Science ®Google Scholar
• Gillespie GM, Wills MR, Appay V et al. Functional hetero-geneity and high frequencies of cytomegalovirus-specific CD8(+ ) T lymphocytes in healthy seropositive donors. J Virol 2000;74:8140–50.
   PubMed Web of Science ®Google Scholar
• McLaughlin-Taylor E, Pande H, Forman SJ etal. Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for 008 + virus-specific cytotoxic T lympho-cytes. J Med Vim 1994;43: 103— 10.
   Google Scholar
• Wills MR, Carmichael AJ, Mynard K et al. The human cyto-toxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol 1996;70:7569–79.
   PubMed Web of Science ®Google Scholar
• Diamond DJ, York J, Sun JY etal. Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection. Blood 1997;90:1751–67.
   Google Scholar
• Solache A, Morgan CL, Dodi Al et al. Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cyto-megalovirus protein pp65 that are conserved between eight strains of the virus. J Immunol 1999;163:5512–8.
   PubMed Web of Science ®Google Scholar
• Ostrowski MA,Justement SJ, Ehler L etal. The role of C D4+ Tcell help and CD40 ligand in the in vitro expansion of HIV-1-specific memory cytotoxic 008 + T cell responses. J Immunol 2000;165:6133–41.
   Google Scholar
• Schoenberger SP, Toes RE, van der Voort El etal. T-cell help for cytotoxic T lymphocytes is mediated by CD40 —CD4OL inter-actions. Nature 1998;393:480–3.
   Google Scholar
• Bennett SR, Carbone FR, Karamalis F etal. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998;393:478–80.
   Google Scholar
• Janssen EM, Lemmens EE, Wolfe T etal. C D4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 2003;421:852–6.
   Google Scholar
• Kalams SA, Walker BD etal. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J Exp Med 1998;188:2199–204.
   PubMed Web of Science ®Google Scholar
• Zajac AJ, Blattman JN, Murali-Krishna K etal. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 1998;188:2205–13.
   Google Scholar
• Taylor PA, Noelle RJ, Blazar BR et al. CD4(+ )CD25( +) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001;193:1311–8.
   PubMed Web of Science ®Google Scholar
• Hoffmann P, Ermann J, Edinger M et a/. Donor-type CD4(+)CD25( + ) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow trans-plantation. J Exp Med 2002;196:389–99.
   Google Scholar
• Cohen JL, Trenado A, Vasey D et al. CD4(+ )CD25(+) immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp Med 2002;196:401–6.
   PubMed Web of Science ®Google Scholar
• Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activatedand expanded CD4( + )CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002;99: 3493–9.
   Google Scholar